Company profile
Rennova Health, Inc.
OTC: RNVA · Healthcare · Medical - Diagnostics & Research
#557 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ 50GM —SS 65
v0.1 · 25/100 weight · pillars only
↑ listing tenure, operating margin · ↓ Altman-Z, balance-sheet leverage
Methodology →Revenue TTM
$18.7M
Rev growth YoY (TTM)
+43.3%
Net income (FY)
-$7.7M
Employees
96
as of 2026-08-24
Market cap
$4.3M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$18.7M$18.7M2023
Net income-$7.7M-$7.7M2023
Operating income$1.4M$1.4M2023
Total assets$20.3M$20.3M2023
Liabilities$57.1M$57.1M2023
Equity-$36.8M-$36.8M2023
Revenue trend
FY2015 – FY2023 · USD
FY15
FY18
FY18
FY19
FY20
FY21
FY22
FY23
Revenue by segment
Filed disclosures · FY2013
By product
Genomics based technology information100%
Solar power management services0%
By geography
Not disclosed.
The read
What is Rennova Health, Inc.’s revenue?
Rennova Health, Inc. booked $18.7M in FY2023 revenue, growing 43% year over year — faster than most Healthcare companies we track, at a -41.4% net margin.
Peers · Healthcare
Nephros, Inc.75B+Ethema Health Corporation57CAurora Spine Corporation65BOmniAb, Inc.50DFuse Medical, Inc.——PD-Rx Pharmaceuticals, Inc.70BNeighbors
Palm Beach →Key facts
CEOSeamus Lagan
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersWest Palm Beach, FL
ExchangeOTC: RNVA
Employees96
IPO date1995-10-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.